S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q1 2022

Perceptive Advisors

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$4.99B
Total portfolio value
Positions
135
Reported securities
Top Holding
9.5% $474.1M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
TRAVERE THERAPEUTICS INC$474.1M9.50%β€”β€”
9.5%
FOLDAMICUS THERAPEUTICS INC$260.9M5.23%β€”β€”
5.2%
SWTXSPRINGWORKS THERAPEUTICS INC$255.6M5.12%β€”β€”
5.1%
LIANYLIANBIO$208.9M4.19%$0.00$0.12
4.2%
IOVAIOVANCE BIOTHERAPEUTICS INC$203.2M4.07%$16.65$4.31-74.1%
4.1%
MRTXMIRATI THERAPEUTICS INC$195.7M3.92%β€”β€”
3.9%
AGRXXXXXAGILE THERAPEUTICS INC$178.4M3.57%β€”β€”
3.6%
CERECEREVEL THERAPEUTICS HLDNG I$178.1M3.57%β€”β€”
3.6%
HZNPHORIZON THERAPEUTICS PLC$142.9M2.86%β€”β€”
2.9%
GBTGLOBAL BLOOD THERAPEUTICS IN$134.8M2.70%β€”β€”
2.7%
CRNXCRINETICS PHARMACEUTICALS IN$113.3M2.27%$21.95$42.23+92.4%
2.3%
MGTXMEIRAGTX HLDGS PLC$96.2M1.93%$13.85$13.92+0.5%
1.9%
RXDXPROMETHEUS BIOSCIENCES INC$92.2M1.85%β€”β€”
1.9%
COLLEGIUM PHARMACEUTICAL INC$89.5M1.79%β€”β€”
1.8%
ISEEIVERIC BIO INC$87.9M1.76%β€”β€”
1.8%
VBIVXXXXVBI VACCINES INC CDA$86.9M1.74%β€”β€”
1.7%
OMOUTSET MED INC$85.5M1.71%$681.00$4.72-99.3%
1.7%
APLSAPELLIS PHARMACEUTICALS INC$75.3M1.51%$50.81β€”
1.5%
XENEXENON PHARMACEUTICALS INC$73.7M1.48%$30.57$60.96+99.4%
1.5%
ALBOALBIREO PHARMA INC$70.4M1.41%β€”β€”
1.4%
RAPTRAPT THERAPEUTICS INC$61.6M1.23%β€”β€”
1.2%
CHRSCOHERUS BIOSCIENCES INC$60.6M1.21%$12.91$1.45-88.8%
1.2%
RLAYRELAY THERAPEUTICS INC$58.2M1.16%$29.93$18.65-37.7%
1.2%
BLUBELLUS HEALTH INC NEW$56.0M1.12%β€”β€”
1.1%
PRCTPROCEPT BIOROBOTICS CORP$52.1M1.04%$34.99$21.03-39.9%
1.0%
CCCCC4 THERAPEUTICS INC$50.5M1.01%$24.26$4.30-82.3%
1.0%
TVTXTRAVERE THERAPEUTICS INC$47.6M0.95%$25.77$56.92+120.9%
0.9%
ATHAATHIRA PHARMA INC$46.3M0.93%β€”β€”
0.9%
COHERUS BIOSCIENCES INC$44.6M0.89%β€”β€”
0.9%
ALDXALDEYRA THERAPEUTICS INC$44.0M0.88%$4.45$2.27-49.0%
0.9%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (8)

TickerIssuerNotional
TRAVERE THERAPEUTICS INC$474.1M
CINCCINCOR PHARMA INC$40.7M
PENPENUMBRA INC$31.9M
ALNYALNYLAM PHARMACEUTICALS INC$29.4M
AXNXAXONICS INC$21.4M
AMLXAMYLYX PHARMACEUTICALS INC$18.9M
RCUSARCUS BIOSCIENCES INC$12.8M
EVHEVOLENT HEALTH INC$8.1M

Exited Positions (8)

TickerIssuerNotional
TRAVERE THERAPEUTICS INC$484.7M
BMRNBIOMARIN PHARMACEUTICAL INC$104.3M
NEVRO CORP$101.5M
ARNAARENA PHARMACEUTICALS INC$46.5M
KODKODIAK SCIENCES INC$44.1M
UTHRUNITED THERAPEUTICS CORP DEL$20.3M
VTRSVIATRIS INC$13.6M
FLNACASSAVA SCIENCES INC$13.1M

Increased (8)

TickerIssuerNotionalShares Ξ”
NVRONEVRO CORP$32.6M+1979.0%
LEGNLEGEND BIOTECH CORP$13.6M+225.8%
MDGLMADRIGAL PHARMACEUTICALS INC$20.0M+222.1%
NUVLNUVALENT INC$10.1M+133.5%
DICEDICE THERAPEUTICS INC$11.2M+115.0%
AORTARTIVION INC$6.5M+88.7%
ZYMEZYMEWORKS INC$-25.4M+44.7%
ACCDACCOLADE INC$-0.2M+44.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
ACADACADIA PHARMACEUTICALS INC$-30.1M-82.0%
SRZNSURROZEN INC$-2.4M-81.2%
NEPTNEPTUNE WELLNESS SOLUTIONS I$-3.7M-80.1%
NVTAQINVITAE CORP$-19.8M-65.0%
GRPHGRAPHITE BIO INC$-8.9M-61.7%
ACRSACLARIS THERAPEUTICS INC$-4.8M-50.9%
RPIDRAPID MICRO BIOSYSTEMS INC$-2.8M-50.5%
BBIOBRIDGEBIO PHARMA INC$-79.9M-46.1%
← Back to Hedge Funds